Maven Clinic Just Raises $90 Million Series E Round of Funding

Maven has had a banner year, with a 5x increase in covered lives; growth has accelerated due to demand for Maven's Global Fertility & Maternity Bundle.
Maven Clinic


Maven Clinic, the world’s largest virtual clinic for women’s and family health, announced today a $90 million Series E funding round led by General Catalyst, with participation from CVS Health Ventures, La Famiglia, and Intermountain Ventures, as well as existing investors Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. This increases Maven’s total investment to $300 million, demonstrating the expanding worldwide need for women’s and family health services.

Maven will use the new funds to continue to invest in personalization across its platform in order to drive meaningful outcomes in both commercial and Medicaid populations, to improve resource localization to meet the cultural and country-specific needs of its global members, and to increase depth of support across all family and reproductive health life stages.

Maven has led the category in innovation since 2014, providing the only end-to-end global reproductive health and family care platform that integrates support throughout the entire family journey, from fertility and family building to maternity, parenting, pediatrics, and menopause.

Maven collaborates with employers and health plans to create inclusive family benefit design, promote health equity, decrease healthcare costs, attract and retain talent, and enhance clinical results by combining integrated benefit coverage and continuous virtual care delivery. Maven’s technology platform provides users in 175 countries with 24/7 virtual care, simple financial reimbursement, peer groups, and concierge service.

Maven’s purpose of providing fair access to care to women and families worldwide has never been more important. With nearly one-third of US women of reproductive age living in states with abortion restrictions, 15% of reproductive-age couples worldwide are infertile.

Jennifer Schneider, M.D., M.S., co-founder and CEO of Homeward and former President of Livongo Health; Yvette Bright, former Chief Operating Officer of Independence Blue Cross; and Chris Klomp, technology entrepreneur and former CEO and Chairman of Collective Medical, have also been appointed as independent board members by Maven.

Related Stories

Latest News Stories

Discover more from Silicon Valley Journals

Subscribe now to keep reading and get access to the full archive.

Continue reading